article · Neuro-Oncology Advances
Background: Automated brain tumor segmentation on multi-parametric magnetic resonance imaging (mpMRI) is crucial in assessing patient outcomes and remains a challenge across Sub-Saharan Africa (SSA). Since 2012, the Brain Tumor Segmentation (BraTS) Challenge has evaluated state-of-the-art artificial intelligence (AI) methods to detect, characterize, and classify tumors. However, it is unclear if these methods can generalize, and hence be widely implemented, in SSA populations. To address this, the BraTS-Africa challenge was conducted in 2023 and 2024 to evaluate population-specific AI models for automated segmentation of brain tumors on mpMRI from the region. Methods: Preoperative T1-weighted, T1-contrast enhanced, T2-weighted, and T2-FLAIR brain MRI scans of 115 patients diagnosed with adult diffuse glioma were curated, annotated, and utilized for the Challenge. Participants were invited to develop and validate their methods. The participating teams were evaluated using weighted Dice Score Coefficient (DSC) and 95% Hausdorff Distance (HD95). Results: In the 2023 challenge a total of 9 teams with participants from 12 countries met the submission criteria and were ranked. The 2024 challenge featured 6 teams from 7 countries. Compared to 2023, the six top ranked methods from 2024 had higher DSC (9.4%) and lower HD95 (57.21%). Conclusions: Together, the 2023 and 2024 challenges provided a unique opportunity to include brain mpMRI glioma cases from SSA in global efforts to develop and evaluate AI methods for the detection of glioma boundaries and their quantification, where the potential of AI solutions to transform healthcare into resource-limited settings is more likely.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1093/noajnl/vdag082
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.